# To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema

> **NCT00371111** · PHASE1 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Resistant Cystoid Macular Edema

## Interventions

- **DRUG:** Intravitreal injection of Triamcinolone
- **DRUG:** Intravitreal injection of Avastin

## Key facts

- **NCT ID:** NCT00371111
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-08
- **Primary completion:** 2008-05
- **Final completion:** 2008-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2008-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371111, "To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00371111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*